CTOs on the Move


 
Stago is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.stago.com
  • 5 Century Dr
    Parsippany, NJ USA 07054
  • Phone: 888.291.0415

Executives

Name Title Contact Details

Similar Companies

VeraLight

VeraLight is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Altimate Medical

Altimate Medical is a Morton, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Decision Services

Medical Decision Services is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ApiJect

ApiJect Systems, Corp. is reimagining how injectable medicines can be packaged and delivered to the world. ApiJect`s technology platform is based on a design philosophy of basic interlocking components to create simple and highly-scalable drug delivery devices. Our first product is the ApiJect Prefilled Injector, a single-dose parenteral that is manufactured in two parts: a Blow-Fill-Seal (BFS) Container aseptically filled with medicine or vaccine, and an insulin-style Needle Hub, also made by ApiJect. At the point of care, a healthcare worker attaches these two components in seconds to activate the injector. By using high-speed, high-volume Blow-Fill-Seal plastics technology, we can reliably supply millions of aseptically filled prefilled injectors per month. Simple devices like these will enable ApiJect to fulfill its mission of making injectable medicines safe and available for everyone.

Endotronix

Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure. The Cordella™ Heart Failure System includes a cloud-based disease-management system and a breakthrough implantable wireless pulmonary artery pressure sensor. The seamlessly integrated system enables proactive management and early detection of worsening heart failure, which promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs.